EU-funded Parkinson’s research project launched at University of Luxembourg

News

Author: Almaz OhenePublished: 9 December 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

News image

The EU is funding a €5.9 million research project at the University of Luxembourg that aims to develop new techniques to identify active compounds for use in the treatment of Parkinson’s disease.

Researchers will concentrate on patterns of Parkinson’s disease in which the mitochondria – the part of the cell that takes in nutrients – are damaged by mutations in individual genes.

The project, Systems Medicine of Mitochondrial Parkinson’s Disease (SysMedPD), brings together partner institutions and pharmaceutical companies from across Europe such as Luxembourg, Germany, Ireland, the Netherlands and the UK.

Dr Ronan Fleming, LCSB scientist and SysMedPD coordinator, said: “We estimate that in about 10-20% of all Parkinson’s patients, their mitochondria do not function properly. In order to better diagnose, heal or at least effectively curb the progression of Parkinson’s disease, we must understand this dysfunction of mitochondria in detail.”

Go Back

Share this story

Comments


Related articles


Parkinsons1Day lead

Carers' Corner

Social experiment shows what it’s like to live with Parkinson’s for one day

Parkinsons1Day video project teaches empathy skills

READ MORE
Neha Shadid Chaudry

Advances

This innovative walking stick may change the lives of Parkinson’s patients

Student receives £15,000 grant to develop smart walking stick

READ MORE
Rosemary maguire

Perspectives

Leading campaigners pay tribute to pioneering Parkinson’s nurse

Praising the “huge contribution” of late Parkinson’s specialist nurse

READ MORE